Bioengineering embryonic stem cell microenvironments for exploring inhibitory effects on metastatic breast cancer cells

Biomaterials

Volumn 32, Issue 17, 2011, Pages 4130-4139

  Raof, Nurazhani Abdul ^a   Raja, Waseem K ^a,b   Castracane, James ^a   Xie, Yubing ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b Tufts University   (United States)

Author keywords

Alginate; Breast cancer cell; Co culture; Metastasis; Microenvironment; Stem cell

Indexed keywords

3D CULTURE; ALGINATE HYDROGELS; AVERAGE VELOCITY; BREAST CANCER; BREAST CANCER CELLS; CANCER CELLS; COCULTURE; EMBRYONIC STEM CELLS; ES CELLS; IN-VITRO; INHIBITORY EFFECT; METASTASIS; MICROBEADS; MICROENVIRONMENTS; NEW OPTIONS; TUMOR CELLS; TUMOR SPHEROID; TUMORIGENESIS;

ALGINATE; DISEASES; FUNCTIONAL POLYMERS; GENES; HYDROGELS; PATHOLOGY; STEM CELLS; THREE DIMENSIONAL; TUMORS;

CELL CULTURE;

ALGINIC ACID;

ANIMAL CELL; ARTICLE; BIOENGINEERING; BREAST CANCER; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; EMBRYONIC STEM CELL; HYDROGEL; METASTASIS; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; VELOCITY;

ANIMALS; BIOENGINEERING; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL PROLIFERATION; COCULTURE TECHNIQUES; EMBRYONIC STEM CELLS; FEMALE; HYDROGELS; MICE; NEOPLASM METASTASIS; RATS;

HARNESS;

EID: 79953271040     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.035     Document Type: Article

References (107)

1. Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007, 7(10):737-749.
2. Mehlen P., Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006, 6(6):449-458.
3. Roennov-Jessen L., Bissell M.J. Breast cancer by proxy: can the microenvironment be both the cause and consequence?. Trends Mol Med 2009, 15(1):5-13.
4. Bissell M.J., LaBarge M.A. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?. Cancer Cell 2005, 7(1):17-23.
5. Weigelt B., Bissell M.J. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 2008, 18(5):311-321.
6. Ma X.-J., Dahiya S., Richardson E., Erlander M., Sgroi D. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 2009, 11(1). R7/1-18.
7. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9(4):239-252.
8. Postovit L.-M., Margaryan N.V., Seftor E.A., Kirschmann D.A., Lipavsky A., Wheaton W.W., et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A 2008, 105(11):4329-4334.
9. Wang X., Sun L., Maffini M.V., Soto A., Sonnenschein C., Kaplan D.L. A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function. Biomaterials 2010, 31(14):3920-3929.
10. Peerani R., Rao B.M., Bauwens C., Yin T., Wood G.A., Nagy A., et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J 2007, 26(22):4744-4755.
11. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008, 40(5):499-507.
12. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10(6):515-527.
13. Douglas T.R., Charles M.P. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers 2001, 17(2):99-109.
14. Shay J.W., Wright W.E. Tissue culture as a hostile environment: identifying conditions for breast cancer progression studies. Cancer Cell 2007, 12(2):100-101.
15. Pampaloni F., Reynaud E.G., Stelzer E.H.K. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2007, 8(10):839-845.
16. Postovit L.-M., Seftor E.A., Seftor R.E.B., Hendrix M.J.C. A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells. Stem Cells 2006, 24(3):501-505.
17. Tzukerman M., Rosenberg T., Reiter I., Ben-Eliezer S., Denkberg G., Coleman R., et al. The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res 2006, 66(7):3792-3801.
18. Lacroix M., Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004, 83(3):249-289.
19. van Staveren W.C.G., Solis D.Y.W., Hebrant A., Detours V., Dumont J.E., Maenhaut C. Human cancer cell lines: experimental models for cancer cells in situ? For cancer stem cells?. Biochim Biophys Acta 2009, 1795(2):92-103.
20. Abdul Raof N., Schiele N.R., Xie Y., Chrisey D.B., Corr D.T. The maintenance of pluripotency following laser direct-write of mouse embryonic stem cells. Biomaterials 2011, 32(7):1802-1808.
21. Khademhosseini A., Yeh J., Eng G., Karp J., Kaji H., Borenstein J., et al. Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays. Lab Chip 2005, 5(12):1380-1386.
22. Park J.Y., Takayama S., Lee S.-H. Regulating microenvironmental stimuli for stem cells and cancer cells using microsystems. Integr Biol 2010, 2(5-6):229-240.
23. Mironov V., Visconti R.P., Kasyanov V., Forgacs G., Drake C.J., Markwald R.R. Organ printing: tissue spheroids as building blocks. Biomaterials 2009, 30(12):2164-2174.
24. Loessner D., Stok K.S., Lutolf M.P., Hutmacher D.W., Clements J.A., Rizzi S.C. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 2010, 31(32):8494-8506.
25. Miyoshi H., Ju J., Lee S.M., Cho D.J., Ko J.S., Yamagata Y., et al. Control of highly migratory cells by microstructured surface based on transient change in cell behavior. Biomaterials 2010, 31(33):8539-8545.
26. Rivron N.C., Rouwkema J., Truckenmüller R., Karperien M., De Boer J., Van Blitterswijk C.A. Tissue assembly and organization: developmental mechanisms in microfabricated tissues. Biomaterials 2009, 30(28):4851-4858.
27. Schiele N.R., Corr D.T., Huang Y., Abdul Raof N., Xie Y., Chrisey D.B. Laser-based direct-write techniques for cell printing. Biofabrication 2010, 2. 032001/1-14.
28. Vargo-Gogola T., Rosen J.M. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007, 7(9):659-672.
29. Kievit F.M., Florczyk S.J., Leung M.C., Veiseh O., Park J.O., Disis M.L., et al. Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment. Biomaterials 2010, 31(22):5903-5910.
30. Schindler M., Ahmed I., Kamal J., Nur-E-Kamal A., Grafe T.H., Young Chung H., et al. A synthetic nanofibrillar matrix promotes in vivo-like organization and morphogenesis for cells in culture. Biomaterials 2005, 26(28):5624-5631.
31. Moraes C., Wang G., Sun Y., Simmons C.A. A microfabricated platform for high-throughput unconfined compression of micropatterned biomaterial arrays. Biomaterials 2010, 31(3):577-584.
32. Marklein R.A., Burdick J.A. Controlling stem cell fate with material design. Adv Mater 2010, 22(2):175-189.
33. Metallo C.M., Mohr J.C., Detzel C.J., De Pablo J.J., Van Wie B.J., Palecek S.P. Engineering the stem cell microenvironment. Biotechnol Prog 2007, 23(1):18-23.
34. Chien K.R. Regenerative medicine and human models of human disease. Nature 2008, 453(7193):302-305.
35. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130(4):601-610.
36. Feder-Mengus C., Ghosh S., Reschner A., Martin I., Spagnoli G.C. New dimensions in tumor immunology: what does 3D culture reveal?. Trends Mol Med 2008, 14(8):333-340.
37. Griffith L.G., Swartz M.A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006, 7(3):211-224.
38. Cushing M.C., Anseth K.S. Hydrogel cell cultures. Science 2007, 316(5828):1133-1134.
39. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294(5547):1708-1712.
40. Cukierman E., Pankov R., Yamada K.M. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002, 14(5):633-640.
41. Khademhosseini A., Langer R. Microengineered hydrogels for tissue engineering. Biomaterials 2007, 28(34):5087-5092.
42. Yang Y., Leong K.W. Nanoscale surfacing for regenerative medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, 2(5):478-495.
43. Bott K., Upton Z., Schrobback K., Ehrbar M., Hubbell J.A., Lutolf M.P., et al. The effect of matrix characteristics on fibroblast proliferation in 3D gels. Biomaterials 2010, 31(32):8454-8464.
44. Bissell M.J., Rizki A., Mian I.S. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003, 15(6):753-762.
45. Lee G.Y., Kenny P.A., Lee E.H., Bissell M.J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Meth 2007, 4(4):359-365.
46. Chung I.M., Enemchukwu N.O., Khaja S.D., Murthy N., Mantalaris A., García A.J. Bioadhesive hydrogel microenvironments to modulate epithelial morphogenesis. Biomaterials 2008, 29(17):2637-2645.
47. Li Y.J., Chung E.H., Rodriguez R.T., Firpo M.T., Healy K.E. Hydrogels as artificial matrices for human embryonic stem cell self-renewal. J Biomed Mater Res A 2006, 79A(1):1-5.
48. Gerecht S., Burdick J.A., Ferreira L.S., Townsend S.A., Langer R., Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A 2007, 104(27):11298-11303.
49. Huebsch N., Arany P.R., Mao A.S., Shvartsman D., Ali O.A., Bencherif S.A., et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 2010, 9(6):518-526.
50. Burdick J.A., Vunjak-Novakovic G. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 2009, 15(2):205-219.
51. Discher D.E., Mooney D.J., Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324(5935):1673-1677.
52. Slaughter B.V., Khurshid S.S., Fisher O.Z., Khademhosseini A., Peppas N.A. Hydrogels in regenerative medicine. Adv Mater 2009, 21(32-33):3307-3329.
53. Li Z., Leung M., Hopper R., Ellenbogen R., Zhang M. Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds. Biomaterials 2010, 31(3):404-412.
54. Wang W., Liu X., Xie Y., Zhang H.A., Yu W., Xiong Y., et al. Microencapsulation using natural polysaccharides for drug delivery and cell implantation. J Mater Chem 2006, 16(32):3252-3267.
55. Augst A.D., Kong H.J., Mooney D.J. Alginate hydrogels as biomaterials. Macromol Biosci 2006, 6(8):623-633.
56. Zhang X., Wang W., Xie Y., Zhang Y., Wang X., Guo X., et al. Proliferation, viability, and metabolism of human tumor and normal cells cultured in microcapsule. Appl Biochem Biotechnol 2006, 134(1):61-76.
57. Yu L., Chen M.C.W., Cheung K.C. Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing. Lab Chip 2010, 10(18):2424-2432.
58. Chen M., Gupta M., Cheung K. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening. Biomed Microdevices 2010, 12(4):647-654.
59. Zhang X., Xie Y., Koh C., James Lee L. A novel 3-D model for cell culture and tissue engineering. Biomed Microdevices 2009, 11(4):795-799.
60. Chayosumrit M., Tuch B., Sidhu K. Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biomaterials 2010, 31(3):505-514.
61. Siti-Ismail N., Bishop A.E., Polak J.M., Mantalaris A. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 2008, 29(29):3946-3952.
62. Wang N., Adams G., Buttery L., Falcone F.H., Stolnik S. Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J Biotechnol 2009, 144(4):304-312.
63. Maguire T., Novik E., Schloss R., Yarmush M. Alginate-PLL microencapsulation: effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol Bioeng 2006, 93(3):581-591.
64. Philippar U., Roussos E.T., Oser M., Yamaguchi H., Kim H.-D., Giampieri S., et al. A mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell 2008, 15(6):813-828.
65. Raja W.K., Gligorijevic B., Wyckoff J., Condeelis J.S., Castracane J. A new chemotaxis device for cell migration studies. Integr Biol 2010, 2(11-12):696-706.
66. Robertson E., Bradley A., Kuehn M., Evans M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 1986, 323(6087):445-448.
67. Keller G., Kennedy M., Papayannopoulou T., Wiles M.V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 1993, 13(1):473-486.
68. Kang X., Xie Y., Powell H.M., James Lee L., Belury M.A., Lannutti J.J., et al. Adipogenesis of murine embryonic stem cells in a three-dimensional culture system using electrospun polymer scaffolds. Biomaterials 2007, 28(3):450-458.
69. Xie Y., Castracane J. High-voltage, electric field-driven micro/nanofabrication for polymeric drug delivery systems. IEEE Eng Med Biol Mag 2009, 28(1):23-30.
70. Sidani M., Wessels D., Mouneimne G., Ghosh M., Goswami S., Sarmiento C., et al. Cofilin determines the migration behavior and turning frequency of metastatic cancer cells. J Cell Biol 2007, 179(4):777-791.
71. Demou Z.N., McIntire L.V. Fully automated three-dimensional tracking of cancer cells in collagen gels. Cancer Res 2002, 62(18):5301-5307.
72. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6(1):17-32.
73. Kashani I., Barvarestani M., Etesam F., Shokrgozar M., Abdolvahabi M., Haddad P., et al. Human preadipocytes inhibit proliferation of MCF-7 breast cancer cell line. Acta Med Iran 2006, 44:291-298.
74. Krause S., Maffini M.V., Soto A.M., Sonnenschein C. A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng Part C Methods 2008, 14(3):261-271.
75. Krause S., Maffini M.V., Soto A.M., Sonnenschein C. The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures. BMC Cancer 2010, 10:263/1-26313.
76. Poczobutt J.M., Tentler J., Lu X., Schedin P.J., Gutierrez-Hartmann A. Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells. BMC Cancer 2010, 10:373/1-37317.
77. Ingthorsson S., Sigurdsson V., Fridriksdottir A., Jonasson J., Kjartansson J., Magnusson M., et al. Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D culture. BMC Res Notes 2010, 3(1):184/1-18412.
78. Sasser A.K., Bethany L.M., Kristen M.S., Adam W.S., Amy E.A., Amanda M.H., et al. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 2007, 254(2):255-264.
79. Pardal R., Clarke M., Morrison S. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902.
80. Strizzi L., Hardy K.M., Seftor E.A., Costa F.F., Kirschmann D.A., Seftor R.E.B., et al. Development and cancer: at the crossroads of nodal and notch signaling. Cancer Res 2009, 69(18):7131-7134.
81. Costa F.F., Seftor E.A., Bischof J.M., Kirschmann D.A., Strizzi L., Arndt K., et al. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 2009, 1(2):387-398.
82. Giuffrida D., Rogers I.M., Nagy A., Calogero A.E., Brown T.J., Casper R.F. Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth. Cell Prolif 2009, 42(6):788-798.
83. Zhou J., Xu R.-H., Wang Y. Nanoporous membrane-encapsulated feeder cells for culture of human embryonic stem cells. Int J Funct Inf Pers Med 2009, 2(1):77-88.
84. Paraic A.K., Genee Y.L., Connie A.M., Richard M.N., Jeremy R.S., Paul T.S., et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007, 1(1):84-96.
85. Weaver V.M., Lelièvre S., Lakins J.N., Chrenek M.A., Jones J.C.R., Giancotti F., et al. Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002, 2(3):205-216.
86. Fournier M.V., Martin K.J., Kenny P.A., Xhaja K., Bosch I., Yaswen P., et al. Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Res 2006, 66(14):7095-7102.
87. Jacks T., Weinberg R.A. Taking the study of cancer cell survival to a new dimension. Cell 2002, 111(7):923-925.
88. Fischbach C., Chen R., Matsumoto T., Schmelzle T., Brugge J.S., Polverini P.J., et al. Engineering tumors with 3D scaffolds. Nat Meth 2007, 4(10):855-860.
89. Hebner C., Weaver V.M., Debnath J. Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures. Annu Rev Pathol 2008, 3(1):313-339.
90. Martin K.J., Patrick D.R., Bissell M.J., Fournier M.V. Prognostic breast cancer signature identified from 3d culture model accurately predicts clinical outcome across independent datasets. PLoS ONE 2008, 3(8). e2994/1-9.
91. Han J., Chang H., Giricz O., Lee G., Baehner F., Gray J., et al. Molecular predictors of 3D morphogenesis by breast cancer cell lines in 3D culture. PLoS Comput Biol 2010, 6(2). e1000684/1-12.
92. Debnath J., Brugge J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005, 5(9):675-688.
93. Markovitz-Bishitz Y., Tauber Y., Afrimzon E., Zurgil N., Sobolev M., Shafran Y., et al. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids. Biomaterials 2010, 31(32):8436-8444.
94. Pickl M., Ries C.H. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 2008, 28(3):461-468.
95. Nam J.-M., Onodera Y., Bissell M.J., Park C.C. Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin and fibronectin. Cancer Res 2010, 70(13):5238-5248.
96. Hakanson M., Textor M., Charnley M. Engineered 3D environments to elucidate the effect of environmental parameters on drug response in cancer. Integr Biol 2011, 3(1):31-38.
97. Doillon C.J., Gagnon E., Paradis R.E., Koutsilieris M. Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity. Anticancer Res 2004, 24(4):2169-2178.
98. Li Q., Chow A.B., Mattingly R.R. Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase inhibitors. J Pharmacol Exp Ther 2010, 332(3):821-828.
99. Zhang X., Wang W., Yu W., Xie Y., Zhang Y., Ma X. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Biotechnol Prog 2005, 21(4):1289-1296.
100. Friedrich J., Ebner R., Kunz-Schughart L.A. Experimental anti-tumor therapy in 3-D: spheroids - old hat or new challenge?. Int J Radiat Biol 2007, 83(11-12):849-871.
101. Brekhman V., Neufeld G. A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion. BMC Cancer 2009, 9(1):415/1-41512.
102. Ma L., Zhou C., Lin B., Li W. A porous 3D cell culture micro device for cell migration study. Biomed Microdevices 2010, 12(4):753-760.
103. Morales J., Alpaugh M. Gain in cellular organization of inflammatory breast cancer: a 3D in vitro model that mimics the in vivo metastasis. BMC Cancer 2009, 9(1). 462/1-12.
104. Mitsiades C., Sourla A., Doillon C., Lembessis P., Koutsilieris M. Three dimensional type I collagen co-culture systems for the study of cell-cell interactions and treatment response in bone metastases. J Musculoskelet Neuronal Interact 2000, 1:153-155.
105. Bissell M.J. Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland. Biochem Soc Trans 2007, 035(1):18-22.
106. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30(30):5897-5909.
107. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29(20):2941-2953.